Couragene
PrivateLast Round
Grant
Sep 19, 2024
Total Funding Raised
$42.94M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Couragene is a biotechnology company that develops gene and biologic therapies using its proprietary Stimuli-responsive Traceless Engineering Platform (STEP) for the delivery of genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Couragene Comparables
Compare Couragene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 86% | |
| Nanite, Inc. | 85% | |
| CyGenica | 83% | |
Couragene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 19, 2024 | ||||
| Grant | Oct 10, 2023 | ||||
| Seed | Sep 6, 2022 |
Couragene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hi2 Global | Seed |
| Foothill Ventures | Seed |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 1047% MoM, reaching 1.6K.
- Apr 5, 2026
Monthly visitors increased 46% MoM.
Couragene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Couragene's valuation, stock price, and market status.